We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Organotypic 3-dimensional Spheroid Cultures Pre-clinical Testing Paradigms

Video   Oct 19, 2016

 

The principles of the 3Rs (reduction, refinement and replacement) alternatives to in vivo testing are being aggressively pursued across the globe for reasons of cost and speed as well as science and ethics. Primary cells in particular express many of the differentiated cellular structures and functions of their source tissues, however short culture periods and loss of organotypic functionality limit their use especially for chronic toxicity studies. 2-D in vitro culture methods such as primary tissue culture and immortalised or transformed cell lines have been used extensively to elucidate specific toxic or biological responses in target or surrogate organs. But these conventional culture methods do not fully represent the growth conditions or 3-D architecture of in vivo tissues. 3-D in vitro studies can provide some of the vital mechanistic knowledge of the functions of different cell types. Instead of keeping cells in a suspension, or plating them out into a film of material in a Petri dish, spheroids are prepared by gyrotatory and other means to form a ‘ball’. Within these ‘balls’ the cells then begin to connect to each other and form a mini-organ or micro-tissue known as a spheroids. The functionality of mature spheroids is similar to that of the tissue in vivo, and the longevity improves up to ten-fold compared to primary cells. Characterisation via a range of assay measures is possible and the models may offer the potential for stem cell studies alongside their pre-clinical applications in toxicity testing and mechanistic studies.


 
 
 
Advertisement
 

Recommended Videos

How To Choose Your Tools for 3D Cell Culture

Video

Join this Teach Me in 10 session to hear Corning Life Sciences application scientists walk you through common research goals and the most suitable 3D cell culture solutions for each.

WATCH NOW

CAR T Cells: A Living Targeted Drug, With Dr Matt Cooper

Video

In this installment of Teach Me in 10, we're joined by Matt Cooper, co-founder and chief scientific officer at Wugen, Inc. He is also assistant professor of medicine at Washington University. Matt discusses what T cells are and how they can be engineered to recognize cancer cells.

WATCH NOW

Meet Shoji Takeuchi – Growing Meat in the Lab

Video

Professor Shoji Takeuchi and his team have created the technology to produce 3D muscle tissue in the lab. Will this cultured steak be on the menu one day?

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE